GlassScriptPhysician profile
Elizabeth Anderson
NPI 1073589925
$8,460.65
in general payments reported to CMS, 2019-2025
39 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $682 · 2021: $1,313 · 2022: $1,672 · 2023: $1,150 · 2024: $1,089 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,600.77 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,077.59 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Novartis Pharmaceuticals Corporation | $1,075.17 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $710.55 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $698.13 | 2019-2025 | Dupixent |
| Genzyme Corporation | $375.82 | 2019-2025 | |
| Pfizer INC. | $305.82 | 2019-2024 | |
| Ucb, INC. | $289.24 | 2019-2025 | Bimzelx |
| Janssen Biotech, INC. | $273.04 | 2019-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $271.87 | 2023-2025 | Zoryve |
| Amgen INC. | $266.42 | 2020-2025 | Otezla, Otezla |
| Almirall LLC | $218.65 | 2019-2025 | Seysara |
| E.R. Squibb & Sons, L.L.C. | $212.88 | 2022-2024 | Sotyktu |
| Incyte Corporation | $212.69 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $187.60 | 2023-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $173.20 | 2019-2025 | Taltz, Olumiant, Ebglyss |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.